Additionally, paclitaxel (PTX)/NCTD nanoparticles modified by tumor neovascular-targeting peptide (APRPG) have been shown to induce apoptosis through AKT and ERK signaling pathways, enhancing the efficacy of anti-liver cancer drugs [31]. Here, AKT1 is linked to liver cancer.